Search Results - "animal models"
Suggested Topics within your search.
Suggested Topics within your search.
- Medicine 67
- Biology, life sciences 41
- Research & information: general 29
- Neurosciences 28
- Pharmacology 15
- Immunology 9
- Neurology & clinical neurophysiology 8
- Science: general issues 8
- Biotechnology 6
- Technology: general issues 6
- Chemistry 5
- Food & society 4
- Genetics (non-medical) 4
- Microbiology (non-medical) 4
- Physiology 4
- Biomedical engineering 3
- Cardiovascular medicine 3
- Humanities 3
- Materials science 3
- Pathology 3
- Psychology 3
- Social interaction 3
- Biochemistry 2
- Biology 2
- Biomaterials 2
- Biomedical Research 2
- Endocrinology 2
- Geriatric medicine 2
- Gynaecology & obstetrics 2
- Infectious & contagious diseases 2
-
3701
Living with brain cancer: From researcher to patient
Published 2022Connect to this object online.
Book -
3702
-
3703
-
3704
-
3705
-
3706
-
3707
-
3708
-
3709
-
3710
-
3711
-
3712
-
3713
-
3714
-
3715
-
3716
-
3717
-
3718
Antisense RNA Design, Delivery, and Analysis
Published 2022Table of Contents: “…Introduction and History of the Chemistry of Nucleic Acids Therapeutics -- Antisense RNA Therapeutics: A Brief Overview -- Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion -- Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation -- How to Design U1 snRNA Molecules for Splicing Rescue -- Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles -- Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay -- Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen -- Development and Use of Cellular Systems to Assess and Correct Splicing Defects -- Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells -- In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin -- In Vitro Delivery of PMOs in Myoblasts by Electroporation -- Rapid Determination of MBNL1 Protein Levels by Quantitative Dot Blot for Evaluation of Antisense Oligonucleotides in Myotonic Dystrophy Myoblasts -- Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy -- Generation of Human iPSC-Derived Myotubes to Investigate RNA-Based Therapies In Vitro -- Eye on a Dish Models to Evaluate Splicing Modulation -- Establishment of In Vitro Brain Models for AON Delivery -- Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides -- Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies -- Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense Treatment -- In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin -- Delivery of Antisense Oligonucleotides to the Mouse Retina -- Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections -- Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System -- Preclinical Safety Assessment of Therapeutic Oligonucleotides -- Preclinical Evaluation of the Renal Toxicity of Oligonucleotide Therapeutics in Mice -- Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution -- Patent Considerations When Embarking on New Antisense Drug Programs.…”
Link to Metadata
Electronic eBook -
3719
Innovative Medicine Basic Research and Development /
Published 2015Link to Metadata
Electronic eBook -
3720
The biology of the first 1000 days
Published 2018DOAB: download the publication
DOAB: description of the publication
Electronic Book Chapter